Early research (Phase 1)Study completedNCT01300533What this trial is testingBIND-014 Given to Patients With Advanced or Metastatic CancerWho this might be right forMetastatic CancerCancerSolid Tumors BIND Therapeutics 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT03902951What this trial is testingAntiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerWho this might be right forMetastatic Prostate AdenocarcinomaProstate Adenocarcinoma With Focal Neuroendocrine DifferentiationRecurrent Prostate Carcinoma+1 more Jonsson Comprehensive Cancer Center 28
Not applicableUnknownNCT04628806What this trial is testingHeat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor CellsWho this might be right forMelanoma Stage IVSarcomaSquamous Cell Carcinoma+3 more Charite University, Berlin, Germany 120
Testing effectiveness (Phase 2)Looking for participantsNCT05914116What this trial is testingA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors DualityBio Inc. 862
Testing effectiveness (Phase 2)Looking for participantsNCT06683846What this trial is testingIvonescimab in the Treatment of Multiple Advanced TumorsWho this might be right forPheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more Fudan University 400
Testing effectiveness (Phase 2)Looking for participantsNCT07341737What this trial is testingSL-28 for Advanced Solid TumoursWho this might be right forHead & Neck CancerPancreas CarcinomaPancreas Cancer, Metastatic+15 more Second Life Therapeutics 60
Early research (Phase 1)Active Not RecruitingNCT03983954What this trial is testingNaptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Who this might be right forER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more NeoTX Therapeutics Ltd. 120
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Early research (Phase 1)UnknownNCT05311618What this trial is testingStudy of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 71
Early research (Phase 1)Looking for participantsNCT06910657What this trial is testingIDOV-Immune for Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerMelanoma+13 more ViroMissile, Inc. 78
Early research (Phase 1)Active Not RecruitingNCT05215574What this trial is testingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 130
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)WithdrawnNCT00769990What this trial is testingGenistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWho this might be right forBreast CancerKidney CancerLung Cancer+4 more Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT05864144What this trial is testingSNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Early research (Phase 1)Temporarily pausedNCT03970382What this trial is testingGene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid TumorsWho this might be right forSolid Tumor PACT Pharma, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT03649841What this trial is testingAntiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forCastration-Sensitive Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+5 more University of Washington 10